General Information of Drug (ID: DMZF0DK)

Drug Name
Aminopyrimidine derivative 6 Drug Info
Synonyms PMID26293650-Compound-43
Cross-matching ID
PubChem CID
51357830
TTD Drug ID
DMZF0DK

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Patented Agent(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
PMID26293650-Compound-34 DMHXT12 N. A. N. A. Patented [1]
PMID26293650-Compound-35 DMPG8MF N. A. N. A. Patented [1]
Pyrimidinyl compound 4 DM53O9Y N. A. N. A. Patented [1]
Aminopyrimidine derivative 10 DM2TF64 N. A. N. A. Patented [1]
Pyrimidinyl compound 7 DMMYW2L N. A. N. A. Patented [1]
Pyrimidinyl compound 1 DMYKHQ8 N. A. N. A. Patented [1]
Aminopyrimidine derivative 7 DMW98RI N. A. N. A. Patented [1]
Pyrimidinyl compound 3 DMOE2FZ N. A. N. A. Patented [1]
Aminopyrimidine derivative 9 DM5VRXW N. A. N. A. Patented [1]
Pyrimidinyl compound 2 DM9TW5O N. A. N. A. Patented [1]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
NF-kappa-B-activating kinase (TBK1) TTH5TC2 TBK1_HUMAN Inhibitor [1]

References

1 TBK1 inhibitors: a review of patent literature (2011 - 2014).Expert Opin Ther Pat. 2015;25(12):1385-96.